Showing results (691-700 of 2,410) with videos related to

Sort By:
Pageof 241
Journal of Medical Economics|September 25, 2019
Primary immune thrombocytopenia in US clinical practice: incidence and healthcare burden in first 12 months following diagnosisDerek Weycker, Ahuva Hanau, Mark Hatfield, et al.
Journal of Medical Economics|July 18, 2019
Modeling the potential impact of abuse-deterrent opioids on medical resource utilizationMihran A Yenikomshian, Alan G White, Michael E Carson, et al.
Journal of Medical Economics|March 14, 2017
Clinical and economic impact of mirabegron compared with antimuscarinics for the treatment of overactive bladder in CanadaZalmai Hakimi, Jameel Nazir, Charles McCrea, et al.
Journal of Medical Economics|March 14, 2017
Cost-consequence analysis of two different active flowable hemostatic matrices in spine surgery patientsD Makhija, M Rock, S Ikeme, et al.
Journal of Medical Economics|March 16, 2017
Cost-effectiveness of combination daclatasvir-sofosbuvir for treatment of genotype 3 chronic hepatitis C infection in the United StatesCatherine Saint-Laurent Thibault, Divya Moorjaney, Michael L Ganz, et al.
Journal of Medical Economics|March 17, 2017
Cost-effectiveness analysis on the use of fidaxomicin and vancomycin to treat Clostridium difficile infection in FranceMaureen Watt, Aurélien Dinh, Alban Le Monnier, et al.
Pageof 241